CSS
AKCA

Cubist Systematic Strategies’s Akcea Therapeutics Inc AKCA Stock Holding History

Cubist Systematic Strategies’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,700
Closed -$51K – 2723
2020
Q2 		$51K Sell
3,700
-18,421
-83% -$284K ﹤0.01% 2272
2020
Q1 		$316K Buy
22,121
+6,587
+42% +$108K 0.01% 1488
2019
Q4 		$263K Buy
+15,534
New +$289K ﹤0.01% 1917
2018
Q2 		– Sell
-7,843
Closed -$201K – 2163
2018
Q1 		$201K Buy
+7,843
New +$169K 0.01% 1403
2017
Q4 		– Sell
-9,728
Closed -$269K – 2185
2017
Q3 		$269K Buy
+9,728
New +$180K 0.02% 1253

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's AKCA Position: Q3 2020 in Review

Cubist Systematic Strategies sold out of Akcea Therapeutics Inc (AKCA) in Q3 2020, closing a stake of 3,700 shares — an estimated $51K sold.

Cubist Systematic Strategies first reported a position in AKCA in Q3 2017 and held it in 5 quarters. The position peaked at $316K in Q1 2020. 98 funds tracked by Wall St. Rank hold AKCA as of Q3 2020.

  • Cubist Systematic Strategies reported no remaining Akcea Therapeutics Inc position as of Q3 2020 after selling out during the quarter.
  • Cubist Systematic Strategies sold 3,700 Akcea Therapeutics Inc shares in Q3 2020, an estimated $51K.
  • Cubist Systematic Strategies first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 5 quarters.
  • Cubist Systematic Strategies's Akcea Therapeutics Inc position peaked at $316K in Q1 2020.
  • 98 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q3 2020.

Based on Cubist Systematic Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.